DNA X delays Q2 10-Q filing, cites convertible debt and consolidation accounting complexities

Reuters2026/08/14 20:13

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

DNA X filed a Form 12b-25 to delay its quarterly report for the period ended June 30, 2026.
Filing delay tied to accounting for sale of convertible debt, variable interest entities under ASC 810, consolidation of DNA X, LLC.
Put option termination on May 27, 2026 triggered a conclusion that DNA X, LLC is fully controlled, requiring GAAP consolidation.
Quarterly report expected on or before the fifth calendar day after the original due date.
Net loss from continuing operations expected near $1 million, versus about $1.9 million a year earlier.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038320), on August 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

DNA X delays Q2 10-Q filing, cites convertible debt and consolidation accounting complexities

You may also like

Crypto prices